Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons Ambrose A. Dunn-Meynell 1 2 , Vanessa H. Routh 3 , Ling Kang 2 , Larry Gaspers 3 and Barry E. Levin 1 2 1 Department of Veterans Affairs Medical Center, East Orange, New Jersey 2 Departme...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2002-07, Vol.51 (7), p.2056-2065 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2065 |
---|---|
container_issue | 7 |
container_start_page | 2056 |
container_title | Diabetes (New York, N.Y.) |
container_volume | 51 |
creator | DUNN-MEYNELL, Ambrose A ROUTH, Vanessa H LING KANG GASPERS, Larry LEVIN, Barry E |
description | Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Ambrose A. Dunn-Meynell 1 2 ,
Vanessa H. Routh 3 ,
Ling Kang 2 ,
Larry Gaspers 3 and
Barry E. Levin 1 2
1 Department of Veterans Affairs Medical Center, East Orange, New Jersey
2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey,
Newark, New Jersey
Abstract
Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase
and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP
ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase
(GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing.
Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in
hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression
in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose
infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired
central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical
role for GK as a regulator of glucosensing in both GE and GI neurons in the brain.
Footnotes
Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont
Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu .
Received for publication 14 March 2002 and accepted in revised form 18 April 2002.
ARC, arcuate nucleus; [Ca 2+ ] i , intracellular C |
doi_str_mv | 10.2337/diabetes.51.7.2056 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmed_primary_12086933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A89269264</galeid><sourcerecordid>A89269264</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</originalsourceid><addsrcrecordid>eNpt0l9v0zAQAHALgVhX-AI8oAiJCYml-E8cJ4-jGqVSYS8g8WY5ziXxltrFTsT27XHXjqqoOluWTj_7bOsQekPwjDImPtVGVTBAmHEyEzOKef4MTUjJypRR8es5mmBMaEpEKc7QeQi3GOM8xkt0Rigu8pKxCdos-lG7O2NVgGQZkqGDZGXuoH9IvkEsMDifuCZ5VAFsMLZNjE0-u6F7SqbX99oMUCfK1v9yS9uZ6jE7Bzt41SffYfTOhlfoRaP6AK_36xT9_HL9Y_41Xd0slvOrVarzTAwpV2VGeU6KRjd1RRnHtKo1xVCWmtKSEt4wmgGtK16wmpeFjlFhVelGgM4Im6KL3bkb736PEAa5NkFD3ysLbgxSkCIXVOAI3_0Hb93obbybpCTeRVCSRXS5Q63qQRrbuPgm3YKF-DRnoTExfVWUNI9jy9MTPEYNa6NP-Q9HPpIB7odWjSHIYrE6openqHZ9Dy3I-IfzmyNOd1x7F4KHRm68WSv_IAmW2y6ST10kOZFCbrsobnq7_5KxWkN92LJvmwje74EKWvWNV1abcHBMCMbjnKKPO9eZtvtjPByqnSj7FwE53yU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216477214</pqid></control><display><type>article</type><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</creator><creatorcontrib>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</creatorcontrib><description>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Ambrose A. Dunn-Meynell 1 2 ,
Vanessa H. Routh 3 ,
Ling Kang 2 ,
Larry Gaspers 3 and
Barry E. Levin 1 2
1 Department of Veterans Affairs Medical Center, East Orange, New Jersey
2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey,
Newark, New Jersey
Abstract
Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase
and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP
ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase
(GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing.
Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in
hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression
in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose
infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired
central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical
role for GK as a regulator of glucosensing in both GE and GI neurons in the brain.
Footnotes
Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont
Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu .
Received for publication 14 March 2002 and accepted in revised form 18 April 2002.
ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited;
GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial
hypothalamic nucleus.
DIABETES</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.51.7.2056</identifier><identifier>PMID: 12086933</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Animals ; Biochemistry and metabolism ; Biological and medical sciences ; Biological transport ; Brain - drug effects ; Brain - enzymology ; Brain - physiology ; Brain research ; Carotid Artery, Internal ; Central nervous system ; Diabetes ; Diabetes research ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic - drug effects ; Genes, fos - drug effects ; Glucokinase - genetics ; Glucokinase - metabolism ; Glucose ; Glucose - administration & dosage ; Glucose - pharmacology ; Glucose metabolism ; In Situ Hybridization ; Infusions, Intra-Arterial ; Insulin ; Neurons ; Neurons - drug effects ; Neurons - enzymology ; Neurons - physiology ; Neuropeptides ; Obesity ; Obesity - metabolism ; Physiological aspects ; Physiological transport ; Physiology ; Rats ; Rats, Sprague-Dawley ; Transcription, Genetic - drug effects ; Vertebrates: nervous system and sense organs ; Weight Gain</subject><ispartof>Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2056-2065</ispartof><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 American Diabetes Association</rights><rights>COPYRIGHT 2002 American Diabetes Association</rights><rights>Copyright American Diabetes Association Jul 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</citedby><cites>FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13773577$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12086933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUNN-MEYNELL, Ambrose A</creatorcontrib><creatorcontrib>ROUTH, Vanessa H</creatorcontrib><creatorcontrib>LING KANG</creatorcontrib><creatorcontrib>GASPERS, Larry</creatorcontrib><creatorcontrib>LEVIN, Barry E</creatorcontrib><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Ambrose A. Dunn-Meynell 1 2 ,
Vanessa H. Routh 3 ,
Ling Kang 2 ,
Larry Gaspers 3 and
Barry E. Levin 1 2
1 Department of Veterans Affairs Medical Center, East Orange, New Jersey
2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey,
Newark, New Jersey
Abstract
Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase
and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP
ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase
(GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing.
Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in
hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression
in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose
infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired
central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical
role for GK as a regulator of glucosensing in both GE and GI neurons in the brain.
Footnotes
Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont
Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu .
Received for publication 14 March 2002 and accepted in revised form 18 April 2002.
ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited;
GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial
hypothalamic nucleus.
DIABETES</description><subject>Animals</subject><subject>Biochemistry and metabolism</subject><subject>Biological and medical sciences</subject><subject>Biological transport</subject><subject>Brain - drug effects</subject><subject>Brain - enzymology</subject><subject>Brain - physiology</subject><subject>Brain research</subject><subject>Carotid Artery, Internal</subject><subject>Central nervous system</subject><subject>Diabetes</subject><subject>Diabetes research</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Genes, fos - drug effects</subject><subject>Glucokinase - genetics</subject><subject>Glucokinase - metabolism</subject><subject>Glucose</subject><subject>Glucose - administration & dosage</subject><subject>Glucose - pharmacology</subject><subject>Glucose metabolism</subject><subject>In Situ Hybridization</subject><subject>Infusions, Intra-Arterial</subject><subject>Insulin</subject><subject>Neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Neurons - physiology</subject><subject>Neuropeptides</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Physiological aspects</subject><subject>Physiological transport</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Transcription, Genetic - drug effects</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>Weight Gain</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0l9v0zAQAHALgVhX-AI8oAiJCYml-E8cJ4-jGqVSYS8g8WY5ziXxltrFTsT27XHXjqqoOluWTj_7bOsQekPwjDImPtVGVTBAmHEyEzOKef4MTUjJypRR8es5mmBMaEpEKc7QeQi3GOM8xkt0Rigu8pKxCdos-lG7O2NVgGQZkqGDZGXuoH9IvkEsMDifuCZ5VAFsMLZNjE0-u6F7SqbX99oMUCfK1v9yS9uZ6jE7Bzt41SffYfTOhlfoRaP6AK_36xT9_HL9Y_41Xd0slvOrVarzTAwpV2VGeU6KRjd1RRnHtKo1xVCWmtKSEt4wmgGtK16wmpeFjlFhVelGgM4Im6KL3bkb736PEAa5NkFD3ysLbgxSkCIXVOAI3_0Hb93obbybpCTeRVCSRXS5Q63qQRrbuPgm3YKF-DRnoTExfVWUNI9jy9MTPEYNa6NP-Q9HPpIB7odWjSHIYrE6openqHZ9Dy3I-IfzmyNOd1x7F4KHRm68WSv_IAmW2y6ST10kOZFCbrsobnq7_5KxWkN92LJvmwje74EKWvWNV1abcHBMCMbjnKKPO9eZtvtjPByqnSj7FwE53yU</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>DUNN-MEYNELL, Ambrose A</creator><creator>ROUTH, Vanessa H</creator><creator>LING KANG</creator><creator>GASPERS, Larry</creator><creator>LEVIN, Barry E</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</title><author>DUNN-MEYNELL, Ambrose A ; ROUTH, Vanessa H ; LING KANG ; GASPERS, Larry ; LEVIN, Barry E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-5a9425618fcfdb23502bdc20e99c229215f324e2db583d598c8c8b0abcf7ec413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Biochemistry and metabolism</topic><topic>Biological and medical sciences</topic><topic>Biological transport</topic><topic>Brain - drug effects</topic><topic>Brain - enzymology</topic><topic>Brain - physiology</topic><topic>Brain research</topic><topic>Carotid Artery, Internal</topic><topic>Central nervous system</topic><topic>Diabetes</topic><topic>Diabetes research</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Genes, fos - drug effects</topic><topic>Glucokinase - genetics</topic><topic>Glucokinase - metabolism</topic><topic>Glucose</topic><topic>Glucose - administration & dosage</topic><topic>Glucose - pharmacology</topic><topic>Glucose metabolism</topic><topic>In Situ Hybridization</topic><topic>Infusions, Intra-Arterial</topic><topic>Insulin</topic><topic>Neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Neurons - physiology</topic><topic>Neuropeptides</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Physiological aspects</topic><topic>Physiological transport</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Transcription, Genetic - drug effects</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUNN-MEYNELL, Ambrose A</creatorcontrib><creatorcontrib>ROUTH, Vanessa H</creatorcontrib><creatorcontrib>LING KANG</creatorcontrib><creatorcontrib>GASPERS, Larry</creatorcontrib><creatorcontrib>LEVIN, Barry E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUNN-MEYNELL, Ambrose A</au><au>ROUTH, Vanessa H</au><au>LING KANG</au><au>GASPERS, Larry</au><au>LEVIN, Barry E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>51</volume><issue>7</issue><spage>2056</spage><epage>2065</epage><pages>2056-2065</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons
Ambrose A. Dunn-Meynell 1 2 ,
Vanessa H. Routh 3 ,
Ling Kang 2 ,
Larry Gaspers 3 and
Barry E. Levin 1 2
1 Department of Veterans Affairs Medical Center, East Orange, New Jersey
2 Department of Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3 Department of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey,
Newark, New Jersey
Abstract
Specialized neurons utilize glucose as a signaling molecule to alter their firing rate. Glucose-excited (GE) neurons increase
and glucose-inhibited (GI) neurons reduce activity as ambient glucose levels rise. Glucose-induced changes in the ATP-to-ADP
ratio in GE neurons modulate the activity of the ATP-sensitive K + channel, which determines the rate of cell firing. The GI glucosensing mechanism is unknown. We postulated that glucokinase
(GK), a high–Michaelis constant ( K m ) hexokinase expressed in brain areas containing populations of GE and GI neurons, is the controlling step in glucosensing.
Double-label in situ hybridization demonstrated neuron-specific GK mRNA expression in locus ceruleus norepinephrine and in
hypothalamic neuropeptide Y, pro-opiomelanocortin, and γ-aminobutyric acid neurons, but it did not demonstrate this expression
in orexin neurons. GK mRNA was also found in the area postrema/nucleus tractus solitarius region by RT-PCR. Intracarotid glucose
infusions stimulated c- fos expression in the same areas that expressed GK. At 2.5 mmol/l glucose, fura-2 Ca 2+ imaging of dissociated ventromedial hypothalamic nucleus neurons demonstrated GE neurons whose intracellular Ca 2+ oscillations were inhibited and GI neurons whose Ca 2+ oscillations were stimulated by four selective GK inhibitors. Finally, GK expression was increased in rats with impaired
central glucosensing (posthypoglycemia and diet-induced obesity) but was unaffected by a 48-h fast. These data suggest a critical
role for GK as a regulator of glucosensing in both GE and GI neurons in the brain.
Footnotes
Address correspondence and reprint requests to Barry E. Levin, MD, Neurology Service (127C), VA Medical Center, 385 Tremont
Ave., East Orange, NJ 07018-1095. E-mail: levin{at}umdnj.edu .
Received for publication 14 March 2002 and accepted in revised form 18 April 2002.
ARC, arcuate nucleus; [Ca 2+ ] i , intracellular Ca 2+ ; DIO, diet-induced obesity; DR, diet resistance; GE, glucose-excited; GFAP, glial fibrillary acidic protein; GI, glucose-inhibited;
GK, glucokinase; HBSS, Hanks’ balanced salt solution; IC 50 , half-maximal inhibitory concentration; K ATP channel, ATP-sensitive K + channel; NG, nonglucosensing; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, pro-opiomelanocortin; VMN, ventromedial
hypothalamic nucleus.
DIABETES</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12086933</pmid><doi>10.2337/diabetes.51.7.2056</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1797 |
ispartof | Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2056-2065 |
issn | 0012-1797 1939-327X |
language | eng |
recordid | cdi_pubmed_primary_12086933 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Biochemistry and metabolism Biological and medical sciences Biological transport Brain - drug effects Brain - enzymology Brain - physiology Brain research Carotid Artery, Internal Central nervous system Diabetes Diabetes research Fundamental and applied biological sciences. Psychology Gene Expression Regulation, Enzymologic - drug effects Genes, fos - drug effects Glucokinase - genetics Glucokinase - metabolism Glucose Glucose - administration & dosage Glucose - pharmacology Glucose metabolism In Situ Hybridization Infusions, Intra-Arterial Insulin Neurons Neurons - drug effects Neurons - enzymology Neurons - physiology Neuropeptides Obesity Obesity - metabolism Physiological aspects Physiological transport Physiology Rats Rats, Sprague-Dawley Transcription, Genetic - drug effects Vertebrates: nervous system and sense organs Weight Gain |
title | Glucokinase Is the Likely Mediator of Glucosensing in Both Glucose-Excited and Glucose-Inhibited Central Neurons |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T10%3A34%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucokinase%20Is%20the%20Likely%20Mediator%20of%20Glucosensing%20in%20Both%20Glucose-Excited%20and%20Glucose-Inhibited%20Central%20Neurons&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=DUNN-MEYNELL,%20Ambrose%20A&rft.date=2002-07-01&rft.volume=51&rft.issue=7&rft.spage=2056&rft.epage=2065&rft.pages=2056-2065&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.51.7.2056&rft_dat=%3Cgale_pubme%3EA89269264%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216477214&rft_id=info:pmid/12086933&rft_galeid=A89269264&rfr_iscdi=true |